|
TGTX
Tg Therapeutics, Inc.
TGTX · Q4 FY2023
|
Q4 FY2023 |
|
TGTX Q4 FY2023 transcript
|
|
EDIT
Editas Medicine, Inc.
EDIT · Q4 FY2023
|
Q4 FY2023 |
|
EDIT Q4 FY2023 transcript
|
|
AVIR
Atea Pharmaceuticals, Inc.
AVIR · Q4 FY2023
|
Q4 FY2023 |
|
AVIR Q4 FY2023 transcript
|
|
RXST
RxSight, Inc.
RXST · Q4 FY2023
|
Q4 FY2023 |
|
RXST Q4 FY2023 transcript
|
|
TASK
TaskUs, Inc.
TASK · Q4 FY2023
|
Q4 FY2023 |
|
TASK Q4 FY2023 transcript
|
|
DH
Definitive Healthcare Corp.
DH · Q4 FY2023
|
Q4 FY2023 |
|
DH Q4 FY2023 transcript
|
|
XPER
Xperi Inc.
XPER · Q4 FY2023
|
Q4 FY2023 |
|
XPER Q4 FY2023 transcript
|
|
DAKT
Daktronics Inc /Sd/
DAKT · Q2 FY2024
|
Q2 FY2024 |
|
DAKT Q2 FY2024 transcript
|
|
SBGI
Sinclair, Inc.
SBGI · Q4 FY2023
|
Q4 FY2023 |
|
SBGI Q4 FY2023 transcript
|
|
MRAM
Everspin Technologies Inc.
MRAM · Q4 FY2023
|
Q4 FY2023 |
|
MRAM Q4 FY2023 transcript
|
|
TPC
Tutor Perini Corp
TPC · Q4 FY2023
|
Q4 FY2023 |
|
TPC Q4 FY2023 transcript
|
|
EME
EMCOR Group, Inc.
EME · Q4 FY2023
|
Q4 FY2023 |
|
EME Q4 FY2023 transcript
|
|
AAON
Aaon, Inc.
AAON · Q4 FY2023
|
Q4 FY2023 |
|
AAON Q4 FY2023 transcript
|
|
FWONA
Liberty Media Corp
FWONA · Q4 FY2023
|
Q4 FY2023 |
|
FWONA Q4 FY2023 transcript
|
|
FIGS
FIGS, Inc.
FIGS · Q4 FY2023
|
Q4 FY2023 |
|
FIGS Q4 FY2023 transcript
|
|
KTB
Kontoor Brands, Inc.
KTB · Q4 FY2023
|
Q4 FY2023 |
|
KTB Q4 FY2023 transcript
|
|
OSW
ONESPAWORLD HOLDINGS Ltd
OSW · Q4 FY2023
|
Q4 FY2023 |
|
OSW Q4 FY2023 transcript
|
|
BBSI
Barrett Business Services Inc
BBSI · Q4 FY2023
|
Q4 FY2023 |
|
BBSI Q4 FY2023 transcript
|
|
PNTG
Pennant Group, Inc.
PNTG · Q4 FY2023
|
Q4 FY2023 |
|
PNTG Q4 FY2023 transcript
|
|
UWMC
UWM Holdings Corp
UWMC · Q4 FY2023
|
Q4 FY2023 |
|
UWMC Q4 FY2023 transcript
|
|
CRNX
Crinetics Pharmaceuticals, Inc.
CRNX · Q4 FY2023
|
Q4 FY2023 |
|
CRNX Q4 FY2023 transcript
|
|
DIN
Dine Brands Global, Inc.
DIN · Q4 FY2023
|
Q4 FY2023 |
|
DIN Q4 FY2023 transcript
|
|
PSNL
Personalis, Inc.
PSNL · Q4 FY2023
|
Q4 FY2023 |
|
PSNL Q4 FY2023 transcript
|
|
WRBY
Warby Parker Inc.
WRBY · Q4 FY2023
|
Q4 FY2023 |
|
WRBY Q4 FY2023 transcript
|